Evidence map›Paper›PMID 39722014›Full record

ArticleMolecular medicine (Cambridge, Mass.)2024

Crosstalk between cancer-associated fibroblasts and non-neuroendocrine tumor cells in small cell lung cancer involves in glycolysis and antigen-presenting features.

Yuanhua Lu, Hui Li, Peiyan Zhao, Xinyue Wang, Wenjun Shao, Yan Liu, Lin Tian, Rui Zhong, Haifeng Liu, Ying Cheng

Abstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Identification ofMolecular medicine reports · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuanhua LuPostdoctoral Research Workstation, Jilin Cancer Hospital, Changchun, 130012, China.
Hui LiMedical Oncology Translational Research Lab, Jilin Cancer Hospital, Changchun, 130012, China.
Peiyan ZhaoMedical Oncology Translational Research Lab, Jilin Cancer Hospital, Changchun, 130012, China.
Xinyue WangPostdoctoral Research Workstation, Jilin Cancer Hospital, Changchun, 130012, China.
Wenjun ShaoPostdoctoral Research Workstation, Jilin Cancer Hospital, Changchun, 130012, China.
Yan LiuMedical Oncology Translational Research Lab, Jilin Cancer Hospital, Changchun, 130012, China.
Lin TianPostdoctoral Research Workstation, Jilin Cancer Hospital, Changchun, 130012, China.
Rui ZhongMedical Oncology Translational Research Lab, Jilin Cancer Hospital, Changchun, 130012, China.
Haifeng LiuJilin Cancer Hospital, Changchun, 130012, China. liuhaifeng529@163.com.
Ying ChengMedical Oncology Translational Research Lab, Jilin Cancer Hospital, Changchun, 130012, China. chengying@csco.org.cn.

Funding

China Association for Science and Technology QT202218Department of Human Resources and Social Security of Jilin Provincial 2023 Post-doctoral funding programDepartment of Science and Technology of Jilin Province 20210204031YYDepartment of Science and Technology of Jilin Province 20240304040SFDepartment of Science and Technology of Jilin Province YDZ202401114ZYTSDepartment of Science and Technology of Jilin Province YDZJ202301ZYTS512Health Commission of Jilin Province 2022JC008National Natural Science Foundation of China 82473000
6 · The paper itself

Abstract

backgroundSmall cell lung cancer (SCLC) is a highly fatal malignancy, the complex tumor microenvironment (TME) is a critical factor affecting SCLC progression. Cancer-associated fibroblasts (CAFs) are crucial components of TME, yet their role in SCLC and the underlying mechanisms during their interaction with SCLC cells remain to be determined.

methodsMicroenvironmental cell components were estimated using transcriptome data from SCLC tissue available in public databases, analyzed with bioinformatic algorithms. A co-culture system comprising MRC5 fibroblasts and SCLC cell lines was constructed. RNA sequencing (RNA-seq) was performed on co-cultured and separately cultured MRC5 and H196 cells to identify differentially expressed genes (DEGs) and enriched signaling pathways. Glycolysis and STING signaling in SCLC cells were assessed using glucose uptake assays, qRT-PCR, and Western blot analysis. Immunohistochemical staining of SCLC tissue arrays quantified α-SMA, HLA-DRA and CD8 expression.

resultsNon-neuroendocrine (non-NE) SCLC-derived CAFs exhibited more abundance and DEGs than NE SCLC-derived CAFs did, which interact with non-NE SCLC cells can induce the enrichment of glycolysis-related genes, increasement of glucose uptake, upregulation of glycolytic signaling proteins in non-NE SCLC cells and accumulation of lactate in the extracellular environment, confirming CAF-mediated glycolysis promotion. Additionally, glycolysis-induced ATP production activated STING signaling in non-NE SCLC cells, which upregulated T cell chemo-attractants. However, CAF abundance did not correlate with CD8 + T cell numbers in SCLC tissues. Additionally, non-NE SCLC cell-educated CAFs exhibited features of antigen-presenting CAFs (apCAFs), as indicated by the expression of major histocompatibility complex (MHC) molecules. Co-localization of HLA-DRA and α-SMA signals in SCLC tissues confirmed apCAF presence. The apCAFs and CD8 + T cells were co-located in the SCLC stroma, and there was a positive correlation between CAFs and regulatory T cell (Treg) abundance.

conclusionOur findings suggest that crosstalk between CAFs and non-NE SCLC cells promotes glycolysis in non-NE SCLC cells, thereby increase T cell chemo-attractant expression via activating STING signaling. On the other hand, it promotes the presence of apCAFs, which probably contributes to CD8 + T cell trapping and Treg differentiation. This study emphasizes the pro-tumor function of CAFs in SCLC by promoting glycolysis and impairing T cell function, providing direction for the development of novel therapeutic approaches targeting CAF in SCLC.

Indexed as

Cancer-Associated FibroblastsGlycolysisLung NeoplasmsSmall Cell Lung CarcinomaTumor MicroenvironmentCell CommunicationCell Line, TumorCoculture TechniquesComputational BiologyGene Expression ProfilingGene Expression Regulation, NeoplasticHumansSignal TransductionTranscriptomeAntigen presentationCAFGlycolysisSCLCSTING signaling

Identifiers

PMID39722014
PMCPMC11669202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.